Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
暂无分享,去创建一个
S. Franceschi | N. Muñoz | S. Gallus | R. Herrero | C. Ferreccio | R. Rajkumar | S. D. Sanjosé | G. Ronco | E. Matos | P. Snijders | G. Clifford | Jo Thomas | M. Molano | S. Vaccarella | N. Hieu | P. Snijders | Jaiye O. Thomas | S. Franceschi | C. Meijer | N. Hieu | H. Shin | G. Clifford | S. Tunsakul | R. Herrero | Pth Anh | S. Sukvirach | P. Anh | S. Sanjosé | C. J. Meijer | Gary M. Clifford | Rolando Herrero | Nubia Muñoz | Salvatore Vaccarella | P. T. Anh | Catterina Ferreccio | Nguyen Trong Hieu | Elena Matos | Mónica Molano | Guglielmo Ronco | de S Sanjose | Sukhon Sukvirach | Jaiyeola Thomas | Silvia Franceschi | H-R Shin | de S Sanjose
[1] S. Franceschi,et al. Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests. , 2005, Journal of the National Cancer Institute.
[2] S. Wacholder,et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. , 2005, The Journal of infectious diseases.
[3] S. Franceschi,et al. Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[4] M. Plummer,et al. Papillomavirus infection in rural women in southern India , 2005, British Journal of Cancer.
[5] C. Wheeler,et al. A study of the impact of adding HPV types to cervical cancer screening and triage tests. , 2005, Journal of the National Cancer Institute.
[6] S. Franceschi,et al. Prevalence of human papillomavirus infection in women in Turin, Italy. , 2005, European journal of cancer.
[7] S. Franceschi,et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] Xavier Castellsagué,et al. Against which human papillomavirus types shall we vaccinate and screen? the international perspective , 2004, International journal of cancer.
[9] J. Peto,et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort , 2004, British Journal of Cancer.
[10] S. Franceschi,et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. , 2004, The Journal of infectious diseases.
[11] L. Patterson. Multiple high-risk HPV infections are common in cervical neoplasia and young women in a cervical screening population , 2004, Journal of Family Planning and Reproductive Health Care.
[12] S. Franceschi,et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study , 2004, British Journal of Cancer.
[13] M. Plummer. Improved estimates of floating absolute risk , 2004, Statistics in medicine.
[14] U Menon,et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study , 2003, The Lancet.
[15] I. Catalá,et al. Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain , 2003, Sexually transmitted diseases.
[16] N. Muñoz,et al. Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina:: A Population-Based Study , 2003, Sexually transmitted diseases.
[17] K. Anastos,et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. , 2003, Journal of the National Cancer Institute.
[18] S. Franceschi,et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis , 2003, British Journal of Cancer.
[19] Michal Abrahamowicz,et al. The natural history of type-specific human papillomavirus infections in female university students. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[20] P. Coursaget,et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. , 2003, The Journal of infectious diseases.
[21] S. Franceschi,et al. HUMAN PAPILLOMAVIRUS INFECTION AMONG WOMEN IN SOUTH AND NORTH VIETNAM , 2003 .
[22] N. Kiviat,et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West‐African women over 35 years of age , 2003, International journal of cancer.
[23] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[24] S. Vansteelandt,et al. Distribution of Human Papillomavirus in a Family Planning Population in Nairobi, Kenya , 2003, Sexually transmitted diseases.
[25] P. Coursaget,et al. Prevalence of human papillomavirus infection in women in Busan, South Korea , 2003, International journal of cancer.
[26] M. Plummer,et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.
[27] B. Qadadri,et al. Distribution of Human Papillomavirus Types in Cervicovaginal Washings From Women Evaluated in a Sexually Transmitted Diseases Clinic , 2002, Sexually transmitted diseases.
[28] A. Hildesheim,et al. Host and viral genetics and risk of cervical cancer: a review. , 2002, Virus research.
[29] B. Thomsen,et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study , 2002, BMJ : British Medical Journal.
[30] S. Franceschi,et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology , 2002, British Journal of Cancer.
[31] B. Lloveras,et al. Human papillomavirus genotypes in rural Mozambique , 2001, The Lancet.
[32] N. Muñoz,et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology , 2001, International journal of cancer.
[33] J. Walboomers,et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age‐related patterns for high‐risk and low‐risk types , 2000, International journal of cancer.
[34] R. Burk,et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems , 1997, Journal of clinical microbiology.
[35] Chien-Jen Chen,et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women , 1997 .
[36] Chien-Jen Chen,et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women , 1997, International journal of cancer.
[37] A G Babiker,et al. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.
[38] Richard Doll,et al. Cancer incidence in five continents : a technical report , 1966 .